OSI Pharmaceuticals

                   

Learn about the World Biotechnology Market Brief (Business Wire)

yahoo.com
53 mins ago 14 related
        

Tuesday November 18, 8:27 am ET NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. Market (2003):...

add comment
                   

HPV Vaccine Effective in Males

cancerconsultants.com
14-Nov-2008 97 related
        

Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine), the vaccine approved for the prevention of cervical cancer and other HPV-related conditions in women, has now been shown to prevent...

add comment
                   

Statins May Reduce PSA Levels

cancerconsultants.com
12-Nov-2008 4 related
        

The use of cholesterol-lowering drugs known as statins is associated with a decline in prostate specific antigen (PSA) levels, according to the results of a study published in the November 5, 2008 issue of the Journal of the...

add comment

AVEO Pharmaceuticals to Present at the Lazard Capital Markets Fifth Annual Healthcare Conference

finanznachrichten.de
12-Nov-2008
        

AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Lazard Capital Markets Fifth Annual Healthcare Conference on Wednesday, November 19, 2008 at...

add comment

OSI Pharmaceuticals to Present at the Lazard Annual Healthcare Conference on Tuesday, November 18,..

euroinvestor.co.uk
11-Nov-2008 3 related
        

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that Dr. Colin Goddard, Chief Executive Officer of OSI Pharmaceuticals, will present at the Lazard Conference in New York, NY on Tuesday, Nov.. - Read more

add comment

The Vanderbilt-Ingram Cancer Center Receives CEO Cancer Gold Standard(TM) Accreditation

finanznachrichten.de
11-Nov-2008 7 related
        

The Vanderbilt-Ingram Cancer Center was accredited with the CEO Cancer Gold Standard™ certification, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to...

add comment

Stocks Advancing Amid Heavy Short Interest - AmeriCredit Corp, Priceline.com Inc, OSI...

pharmiweb.co.uk
10-Nov-2008
        

I have resurrected a scan that focuses on companies that are heavily shorted. The purpose is to find stocks that could be in the midst of a potential short covering rally. More details about the methodology are listed below and...

add comment
                   

Good news for cancer drug maker creates calendar play at OSI Pharma

fxstreet.com
10-Nov-2008 6 related
        

Today's tickers: OSIP, TLB, GM, YHOO, FLR, KBR, DIS & GS OSIP – OSI Pharmaceuticals – Option traders appear to spy an opportunity for higher prices at cancer-prevention drug-manufacturer, OSI, which would build on today's 14.4%...

add comment
themoneytimes.com: Biotechnology company OSI Pharmaceuticals gained an instant fillip in the share market Friday following the success of the drug Tarceva, its joint venture with Genentech Inc., in arresting the spread of lung cancer. themoneytimes.com

Tarceva maker: Study shows drug slows lung cancer

pharmiweb.co.uk
08-Nov-2008 33 related
        

James BernsteinNewsday, Melville, N.Y. Released : Saturday, November 08, 2008 3:00 AM Nov. 8--OSI Pharmaceuticals Inc. of Melville and its partners in an anti-lung cancer drug said Friday that results of a new study they...

add comment

OSI Pharmaceuticals (OSIP) NewsBite - OSIP Jumps on Tarceva Study Results

pharmiweb.co.uk
08-Nov-2008
        

Posted on Friday, November 07, 2008 10:50 AM OSI Pharmaceuticals (NasdaqNM: OSIP) opened at $41.59. So far today, the stock has hit a low of $40.00 and a high of $41.66. OSIP is now trading at $40.81, up $5.41 (15.28%). Over...

add comment
1 2 3 next